GLY-HIS-ORN
| Code | Size | Price |
|---|
| TAR-T31974-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T31974-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Documents
Further Information
Bioactivity:
GLY-HIS-ORN is a peptide.
CAS:
71752-72-2
Molecular Weight:
326.35
Purity:
0.98
SMILES:
[C@H](CC1=CN=CN1)(C(N[C@@H](CCCN)C(O)=O)=O)NC(CN)=O
References
Lewis MA, Williams KM, Fang YY, Schultz FA, Long EC. DNA Cleaving "Tandem-Array" Metallopeptides Activated With KHSO(5): Towards the Development of Multi-Metallated Bioactive Conjugates and Compounds. Curr Bioact Compd. 2014;10(1):13-20. PubMed PMID: 25408625; PubMed Central PMCID: PMC4232849.
Glisi? BD, Rajkovi? S, Zivkovi? MD, Djuran MI. A comparative study of complex formation in the reactions of gold(III) with Gly-Gly, Gly-L-Ala and Gly-L-His dipeptides. Bioorg Chem. 2010 Aug;38(4):144-8. doi: 10.1016/j.bioorg.2010.03.002. Epub 2010 Mar 15. PubMed PMID: 20359733.
Rychlewska U, Warzajtis B, Glisi? BD, Zivkovi? MD, Rajkovi? S, Djuran MI. Monocationic gold(III) Gly-L-His and L-Ala-L-His dipeptide complexes: crystal structures arising from solvent free and solvent-containing crystal formation and structural modifications tuned by counter-anions. Dalton Trans. 2010 Oct 14;39(38):8906-13. doi: 10.1039/c0dt00163e. Epub 2010 Aug 20. PubMed PMID: 20725685.
Kukowska M, Kukowska-Kaszuba M, Dzierzbicka K. In vitro studies of antimicrobial activity of Gly-His-Lys conjugates as potential and promising candidates for therapeutics in skin and tissue infections. Bioorg Med Chem Lett. 2015 Feb 1;25(3):542-6. doi: 10.1016/j.bmcl.2014.12.029. Epub 2014 Dec 16. PubMed PMID: 25556094.